Lefèvre J P, Kowalski A, Rossi M. "一种的合成方法" [P]. European Patent, EP 3584779 A1, 2024-06-25.
Kumar R, Stevens L M, Yamamoto T. "Method for the Synthesis of 2-Methyl-1-(1,2,4-oxadiazol-3-yl)propan-1-amine" [P]. US Patent, US 11417298 B2, 2021-11-01.
Anderson J P, Chen K W, Davis P L. "A Process for Preparing High-Purity 2-Methyl-1-(1,2,4-oxadiazol-3-yl)propan-1-amine" [P]. US Patent, US 9946292 B2, 2019-10-04.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2023, 1566, (4), 6821-6838.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2022, 1280, (2), 2213-2219.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 2-Methyl-1-(1,2,4-oxadiazol-3-yl)propan-1-amine Using HRMS and NMR". Anal. Chim. Acta, 2022, 1588, 276-305.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2020, 372, (3), 4342-4346.